- Home >
- Life Sciences >
- Pharmaceutical >
- Therapy >
Therapy Industry Analysis and Statistics (since 2008 - p3)
All premium reports for Therapy Industry Analysis and Statistics (since 2008 - p3)
61-90 of 150 Premium Reports from 16 Publishers
NeoPharm, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
NeoPharm, Inc. - Financial and Strategic Analysis ReviewSummaryNeoPharm, Inc. (Neopharm) is a biopharmaceutical company that is focused on the discovery, development, and commercialization of drugs for the oncology indications. The company is developing the drugs with the help of two technology plat ...
Industries : Therapy
Protherics PLC - Financial and Strategic Analysis Review
- $ 125
- April 2009
Protherics PLC - Financial and Strategic Analysis ReviewSummaryProtherics PLC (Protherics) is a biopharmaceutical company, engaged in developing, manufacturing and marketing of product candidates in the specialist critical care and oncology segment. The company is having major operations across the ...
Industries : Therapy
Sunesis Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Sunesis Pharmaceuticals, Inc. - Financial and Strategic Analysis ReviewSummarySunesis Pharmaceuticals, Inc. (Sunesis) is a biopharmaceutical company engaged in the discovery, development and marketing of oncology therapeutics for the treatment of solid and hematologic cancers. Its product line consi ...
Industries : Therapy
SuperGen, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
SuperGen, Inc. - Financial and Strategic Analysis ReviewSummarySupergen, Inc. (Supergen) is a pharmaceutical company engaged in the discovery, development and marketing of therapies for treating cancer. It is focused on the development of novel hematology and oncology drugs used by oncologists, hema ...
Industries : Therapy
Cell Therapeutics, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Cell Therapeutics, Inc. - Financial and Strategic Analysis ReviewSummaryCell Therapeutics, Inc. (Cell Therapeutics) is a biopharmaceutical company focusing on the discovery, development and marketing of anti-cancer drugs. The company is having major operations in the U.S. and Europe. Cell Therapeut ...
Industries : Therapy
Celgene Corporation - Financial and Strategic Analysis Review
- $ 125
- April 2009
Celgene Corporation - Financial and Strategic Analysis ReviewSummaryCelgene Corporation (Celgene) is an integrated biopharmaceutical company. It is principally engaged in the research, development, manufacture, and marketing of therapies designed to treat cancer and immune-inflammatory-related disea ...
Industries : Therapy
Onyx Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
- $ 125
- April 2009
Onyx Pharmaceuticals, Inc. - Financial and Strategic Analysis ReviewSummaryOnyx Pharmaceuticals, Inc. (Onyx) is a biopharmaceutical company. The company develops and does research of product candidates for the treatment of indications in Oncology on the basis of its proprietary virus technology. The ...
Industries : Therapy
Brazil Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
- $ 2 500
- April 2009
Brazil Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to Brazil neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and com ...
Industries : Medical Devices, Therapy
Spain Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
- $ 2 500
- April 2009
Spain Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to Spain neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and compa ...
Industries : Medical Devices, Therapy
Japan Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
- $ 2 500
- April 2009
Japan Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to Japan neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and compa ...
Industries : Medical Devices, Therapy
India Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
- $ 2 500
- April 2009
India Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to India neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and compa ...
Industries : Medical Devices, Therapy
Pipeline Insight: Hematological Malignancies Companies target niche indications to facilitate market entry
- $ 11 400
- April 2009
IntroductionThere are 224 different pipeline products in clinical development for hematological malignancies. Twenty-three (10%) of these drugs are in late-phase studies and are forecast to achieve peak sales of $3.5 billion in 2018. Drug developers are keen to replicate the success of the two block ...
Industries : Therapy
Germany Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
- $ 2 500
- April 2009
Germany Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to Germany neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and c ...
Industries : Medical Devices, Therapy
France Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
- $ 2 500
- April 2009
France Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to France neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and com ...
Industries : Medical Devices, Therapy
Australia Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
- $ 2 500
- April 2009
Australia Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to Australia neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution a ...
Industries : Medical Devices, Therapy
Canada Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
- $ 2 500
- April 2009
Canada Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to Canada neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and com ...
Industries : Medical Devices, Therapy
United States Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
- $ 2 500
- April 2009
United States Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to United States neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distri ...
Industries : Medical Devices, Therapy
United Kingdom Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
- $ 2 500
- April 2009
United Kingdom Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to UK neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and ...
Industries : Medical Devices, Therapy
ImmunoGen, Inc - SWOT Analysis
- $ 125
- April 2009
Datamonitor's ImmunoGen, Inc - SWOT Analysis company profile is the essential source for top-level company data and information. ImmunoGen, Inc - SWOT Analysis examines the company?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines a ...
Industries : Therapy
Stakeholder Opinions: Gastric Cancer - Targeted therapies compete for first-to-market status
- $ 3 800
- April 2009
IntroductionGastric cancer incidence in 2009 is forecast to be 197,000 in the seven major pharmaceutical markets (US, Japan, Germany, France, Italy, Spain, and UK). Although, the global incidence has decreased in recent years, mortality remains high, particularly in the US and Europe. Therefore, pre ...
Industries : Therapy
Pipeline Insight: Mild Cognitive Impairment - Unlocking the potential of prodromal Alzheimer's disease and beyond
- $ 11 400
- April 2009
IntroductionMCI is a borderline condition between normal aging and dementia affecting around 23.4 million subjects across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) in 2007, 37% of whom were suffering from prodromal Alzheimer's disease. MCI-specific annual sales a ...
Industries : Therapy
World Prostate Cancer Therapeutics Market
- $ 3 950
- April 2009
- 739 pages
This report analyzes the worldwide markets for Prostate Cancer Therapeutics in US$ Millions. Analytics in the report specifically focuses on revenues generated from hormonal therapies.The report provides separate comprehensive analytics for US, Europe, and Rest of World. Annual forecasts are provide ...
Industries : Therapy
World Multiple Myeloma Therapeutics Market
- $ 3 950
- April 2009
- 493 pages
This report analyzes the US market for Multiple Myeloma Therapeutics in Millions of US$. TThe market for multiple myeloma therapeutics is analyzed by the following Drugs: Thalomid, Revlimid, Velcade, and Others. The market for multiple myeloma therapeutics is also analyzed by the Lines of Treatment ...
Industries : Therapy
Italy Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015
- $ 2 500
- March 2009
Italy Neurology Devices Investment Opportunities, Analysis and Forecasts to 2015SummaryThis report is an essential source for in-depth information and data relating to Italy neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and compa ...
Industries : Medical Devices, Therapy
Multiple Sclerosis Treatment Market: Opportunities for Oral Drugs
- $ 850
- March 2009
- 29 pages
Only about 36% of Multiple Sclerosis (MS) patients are currently treated with MS drugs, this percentage is expected to increase to 56% by 2014 as new oral MS therapies are launched, which shows bright opportunity for oral drugs in multiple sclerosis market. The injectables market is big but leaves c ...
Industries : Pharmaceutical, Therapy
Cancer Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia
- $ 1 495
- March 2009
Life Science Analytics', Cancer Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia contains detailed information on the current drug pipeline. This report provides insight into the pipeline sta ...
Industries : Therapy
Cancer Bladder Cancer
- $ 1 495
- March 2009
Life Science Analytics', Cancer Bladder Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of bladder cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:E ...
Industries : Therapy
Cancer Brain Tumor
- $ 1 495
- March 2009
Life Science Analytics', Cancer Brain Tumor contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of brain tumor drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Each Li ...
Industries : Therapy
Cancer Breast Cancer
- $ 1 495
- March 2009
Life Science Analytics', Cancer Breast Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of breast cancer drugs by company and by stage as well as a summary of the latest news and developments in this area.Scope of the report:Eac ...
Industries : Therapy
Cancer Colorectal Cancer or Colon Cancer
- $ 1 495
- March 2009
Life Science Analytics', Cancer Colorectal Cancer or Colon Cancer contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of colorectal cancer or colon cancer drugs by company and by stage as well as a summary of the latest news and developme ...
Industries : Therapy
reportlinker.com © Copyright 2009. All rights reserved